跳至主要内容
临床试验/NCT05779540
NCT05779540招募中不适用

A New Device to Delay Asphyxiation in Subjects Critically Buried in Avalanche Debris: Efficacy and Pathophysiological Implications

Institute of Mountain Emergency Medicine2 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2023年2月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
26
试验地点
2
主要终点
Time limit

研究概览

简要总结

Survival of fully buried avalanche victims depends in major part on a triad of hypoxia, hypercapnia, and hypothermia and therefore decreases rapidly after complete burial. Besides optimizing companion rescue, which still today and even by trained people often takes more than 15 minutes to the extraction of an avalanche victim, prolonging the ability to breath after critical avalanche burial increases survival probability by giving rescuers more time to find and unbury avalanche victims. Based on previous research, the Norwegian company Safeback SE (Bergen, Norway) developed a new non-medical device using an innovative functional principle. The device, called the Safeback SBX (Safeback SE, Bergen, Norway), should make it possible to prevent asphyxia by delivering fresh air to the air pocket. Company claims to achieve a prolongation of survival up to over 60 minutes, giving companion rescuers as well as professional rescue teams more time to get access to the victim. Technical tests conducted by the developing company already provided some promising results regarding the general functioning. However, this study is needed to provide the scientific evidence of the effectiveness and influence on physiologic parameters buried in snow debris humans under realistic conditions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • healthy ASA I subjects

排除标准

  • ASA class II or higher
  • chronic high degree cardiovascular or pulmonary disease
  • claustrophobia
  • psychiatric or neurological disease
  • long-term medication
  • pregnant woman
  • no informed consent
  • history of fever or serious cough in the past two weeks
  • current Covid-19 symptoms or recently tested positive for Covid-19
  • body temperature ≥ 37.5°on test days.

结局指标

主要结局

Time limit

时间窗: From baseline up to 60 minutes

Reaching a predefined time limit (min)

Physiological threshold

时间窗: From baseline up to 60 minutes

Time to reach a SpO2 threshold up to \<75% (min)

次要结局

  • End-tidal CO2 (EtCO2)(Changes from baseline (measurement at 0 min) -> snow-breathing phase (5min, 15min, and timepoint immediately before interruption [up to 60 min) (countinuous monitoring))
  • Minute ventilation (VE)(Changes from baseline (measurement at 0 min) -> snow-breathing phase (5min, 15min, and timepoint immediately before interruption [up to 60 min) (countinuous monitoring))
  • Cerebral Regional Oxygen Saturation (rSO2)(Changes from baseline (measurement at 0 min) -> snow-breathing phase (5min, 15min, and timepoint immediately before interruption [up to 60 min) (countinuous monitoring))
  • NASA-task load index (NASA-TLX) questionnaire (perceived workload)(Change from basal measurement (before hypoxia exposure) to post-exposure measurement (after hypoxia exposure - up to 60 min))
  • Reactive oxygen species - ROS(Change from basal measurement (before hypoxia exposure) to post-exposure measurement (after hypoxia exposure - up to 60 min))
  • Total antioxidant capacity - TAC(Change from basal measurement (before hypoxia exposure) to post-exposure measurement (after hypoxia exposure - up to 60 min))

研究者

发起方
Institute of Mountain Emergency Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Giacomo Strapazzon, MD PhD

Dr.

Institute of Mountain Emergency Medicine

研究点 (2)

Loading locations...

相似试验

Efficacy and Pathophysiological Implications of a... | 临床试验